The Center for Global Development (CDG), an independent, nonprofit group, has released a report about drug resistant diseases being driven by more access to drugs in underdeveloped nations.
1. Collect and share drug resistance information across disease networks.
2. Secure the drug supply chain to ensure quality products and practices.
3. Strengthen national drug regulatory authorities in developing countries.
4. Catalyze research and innovation to speed the development of resistance-fighting technologies.
Secure Pharma Chain Blog endorses the concept by the CDG that an increased vigilance in securing the supply chain of these programs limits their vulnerability to fraud, adulteration and counterfeiting is one of the most significant steps in ensuring the efficacy of these efforts to fight these deadly diseases.
Poor quality, fraudulent, adulterated and counterfeit drugs are causing millions to die each year from drug resistant strains of diseases that should be easily treated and contained. This epidemic is easily solved by more regulatory control and in the supply chains protecting themselves from criminal acts.To read the entire CDG report, visit: http://www.cgdev.org/section/initiatives/_active/drugresistanceglobalhealth.
To learn more about pharmaceutical supply chain solutions, visit: http://www.xstreamsystems.net/.